Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · IEX Real-Time Price · USD
26.43
+0.09 (0.34%)
May 17, 2024, 4:00 PM EDT - Market closed

Cartesian Therapeutics Market Cap

Cartesian Therapeutics has a market cap or net worth of $470.35 million as of May 20, 2024. Its market cap has increased by 155.49% in one year.

Market Cap
470.35M
Enterprise Value
377.39M
1-Year Change
155.49%
Ranking
Category
Stock Price
$26.43

Market Cap Chart

Since June 22, 2016, Cartesian Therapeutics's market cap has increased from $236.80M to $470.35M, an increase of 98.63%. That is a compound annual growth rate of 9.07%.

History

DateMarket Cap% Change
May 17, 2024470.30M0.34%
May 16, 2024468.70M-1.18%
May 15, 2024474.30M7.67%
May 14, 2024440.50M15.40%
May 13, 2024381.70M1.33%
May 10, 2024376.70M-3.16%
May 9, 2024389.00M-5.99%
May 8, 2024413.80M230.25%
May 7, 2024125.30M-9.86%
May 6, 2024139.00M0.58%
May 3, 2024138.20M4.78%
May 2, 2024131.90M7.94%
May 1, 2024122.20M2.60%
Apr 30, 2024119.10M0.25%
Apr 29, 2024118.80M4.67%
Apr 26, 2024113.50M0.62%
Apr 25, 2024112.80M0.80%
Apr 24, 2024111.90M0.63%
Apr 23, 2024111.20M12.78%
Apr 22, 202498.60M1.96%
Apr 19, 202496.70M3.64%
Apr 18, 202493.30M-6.61%
Apr 17, 202499.90M-1.38%
Apr 16, 2024101.30M-1.17%
Apr 15, 2024102.50M-2.10%
View and export this data all the way back to 2016. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
TScan Therapeutics 474.18M
UroGen Pharma 474.03M
Verve Therapeutics 470.90M
Fulcrum Therapeutics 469.88M
Larimar Therapeutics 468.93M
Talkspace 465.79M
ZimVie 463.36M
Editas Medicine 461.77M
Market Cap Rankings